phrykt

Seaport Therapeutics, Inc. (SPTX): who owns it and who trades it

As of Nov 16, 2026, SPTX insiders reported 3 purchases worth $20.1M in the last 12 months. The largest buyer was ARCH Venture Partners XII, L.P. (10% owner), with $19.8M. 2 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Seaport Therapeutics

From the latest filings

Overall: more buying than selling. Insiders mostly bought. Famous investors was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns SPTX

55 funds and institutions reported SPTX shares worth $816M at the end of Q2 2026, about 70% of the company. The largest holder is ARCH Venture Management, LLC with 11.8%.

Funds and institutions (13F) 70%Everyone else 30%

10 largest owners, by share of the company

ARCH Venture Management, LLC11.8%
General Atlantic, L.P.11.4%
Sofinnova Investments, Inc.6.7%
Goldman Sachs Group Inc4.1%
Trv Gp Vi, LLC3.9%
Canada Pension Plan Investment Board3.7%
JPMorgan Chase & Co3.4%
Foresite Capital Management VI LLC3.3%
T. Rowe Price Associates2.4%
FMR LLC (Fidelity)2.2%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
ARCH Venture Management, LLC6.29M11.76%$137M–
General Atlantic, L.P.6.10M11.40%$133M–
Sofinnova Investments, Inc.3.56M6.66%$77.4M–
Goldman Sachs Group Inc2.18M4.07%$47.3M–
Trv Gp Vi, LLC2.06M3.85%$44.8M–
Canada Pension Plan Investment Board1.98M3.69%$42.9M–
JPMorgan Chase & Co1.82M3.39%$40.9M–
Foresite Capital Management VI LLC1.78M3.32%$38.7M–
T. Rowe Price Associates1.31M2.44%$28.4M–
FMR LLC (Fidelity)1.19M2.21%$25.7M–
Bellevue Group AG1.10M2.05%$23.9M–
Siren, L.L.C.1.10M2.05%$23.8M–
Jennison Associates LLC1.08M2.02%$23.5M–
Ra Capital Management, L.P.700,0001.31%$15.2M–
Vanguard Capital Management LLC599,2171.12%$13M–
Woodline Partners LP586,3451.10%$12.7M–
Braidwell LP500,0000.93%$10.9M–
Perceptive Advisors LLC500,0000.93%$10.9M–
Principal Financial Group Inc414,6720.77%$9M–
Aberdeen Group plc310,3550.58%$6.7M–

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, SPTX insiders reported $20.1M of open-market purchases and $0 of sales.

Purchases, 12 months
$20.1M
3 trades, 3 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
Nov 3, 2026
Filed Nov 4, 2026

Purchases and sales by month

$19.8M$19.8MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 3, 2026Denice TorresDirectorPurchase5,000$19.86$99.3KForm 4
Jun 22, 2026Robert J. HombachDirectorPurchase13,000$18.14$236KForm 4
May 4, 2026ARCH Venture Partners XII, L.P. +610% ownerPurchase1.10M$18.00$19.8MForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
ARCH Venture Partners XII, L.P.10% owner$19.8M–May 4, 2026
Robert J. HombachDirector$236K–Jun 22, 2026
Denice TorresDirector$99.3K–Nov 3, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

SPTX short interest

Moderate short interest. 7.0% of SPTX shares are sold short: about 1 share in 14. Over the last 12 reports the number of shares short went up 156%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 3.73M SPTX shares were sold short, 7.0% of the shares outstanding, up 0.4% from the report before. At the average daily volume of 214,337 shares, buying them all back would take about 17.4 trading days (days to cover).

Shares short, % of all shares

6.97%Jun 15Oct 307.48%

Days to cover

17.4May 15Oct 3035.1

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20263.73M6.97%+0%214,33717.4
Oct 15, 20263.72M6.95%+2%208,07517.9
Sep 30, 20263.65M6.82%+16%408,9538.9
Sep 15, 20263.15M5.88%-0%152,21820.7
Aug 31, 20263.15M5.89%+5%121,33626.0
Aug 14, 20263.01M5.63%+9%119,90425.1
Jul 31, 20262.76M5.15%+39%89,68430.8
Jul 15, 20261.98M3.70%-29%161,22712.3
Jun 30, 20262.78M5.19%+43%362,3957.7
Jun 15, 20261.94M3.62%+11%119,43916.2
May 29, 20261.75M–+20%217,0038.1
May 15, 20261.46M––850,4641.7

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Seaport Therapeutics company events

Seaport Therapeutics filed 4 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Nov 2, 2026.

  1. Nov 2, 2026ResultsReleased financial results. Filing
  2. Aug 3, 2026ResultsReleased financial results. Filing
  3. Jun 8, 2026ResultsReleased financial results. Filing
  4. May 4, 2026RulesChanged its bylaws or articles. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Famous investors that hold SPTX

2 of the 50 well-known investors we track reported holding SPTX in their latest 13F filing. The largest position is Israel Englander's, worth $1.4M.

FundQuarterSharesValueOf portfolioChange
Israel Englander · Millennium ManagementQ3 202667,953$1.4M0.0%+50%
Ken Griffin · Citadel AdvisorsQ3 202624,843$501K0.0%-87%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Seaport Therapeutics, Inc. (SPTX) stock

Who owns the most SPTX stock?

The largest reported owner of Seaport Therapeutics, Inc. (SPTX) is ARCH Venture Management, LLC, with 11.8% of the company. In total, 55 funds and institutions reported holding SPTX at the end of Q2 2026, together about 70% of the shares. See the largest owners.

Are SPTX insiders buying or selling?

In the last 12 months, SPTX insiders reported 3 open-market purchases worth $20.1M and no sales. The latest trade was on Nov 3, 2026. See every trade.

What is the short interest in SPTX?

As of Oct 30, 2026, 3.73M SPTX shares were sold short, 7.0% of the shares outstanding, up 0.4% from the report before. At the average daily volume of 214,337 shares, buying them all back would take about 17.4 trading days (days to cover). See the history.

Which famous investors hold SPTX?

2 of the 50 well-known investors we track reported SPTX in their latest 13F filing, including Israel Englander, Ken Griffin. The largest position is worth $1.4M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.